Genosco’s pipelines consist of 2 assets in Phase II, 1 asset in Phase I and multiple preclinical programs.
Genosco is a clinical-stage biotechnology company pursuing the discovery and development
of novel small-molecule drugs to treat patients with unmet medical needs.
